Impact of Pulmonary Rehabilitation on Loneliness in COPD
Effect of Pulmonary Rehabilitation on Reducing Loneliness in Individuals With Chronic Obstructive Pulmonary Disease (COPD)
1 other identifier
interventional
45
1 country
1
Brief Summary
Loneliness is the feeling of sadness because one wants friends or company. This feeling is common in patients with chronic lung disease, who suffer from breathing difficulty, chronic cough, and reduced physical and mental health. These problems lead to a reduced ability for doing daily activities and cause a loss of social life. Pulmonary rehabilitation (PR) includes exercise and education. PR has been shown to improve health status in patients with chronic lung disease but its impact on loneliness levels has never been assessed. This study aims to assess the effect of PR on reducing loneliness in patients with chronic lung disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2022
CompletedFirst Posted
Study publicly available on registry
June 28, 2022
CompletedStudy Start
First participant enrolled
January 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedMay 23, 2025
May 1, 2025
9 months
June 22, 2022
May 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The University of California and Los Angeles Loneliness scale (UCLA-LS)
Loneliness questionnaire. The UCLA-LS is a 20-item scale used to assess loneliness in the general population. Participants respond to each item on a 1-4 Likert scale, from "never" to "always". Positively worded items are reverse scored. The scale has a possible total score of 20 to 80 points, with a higher score indicating greater loneliness
10 months
Secondary Outcomes (4)
Chronic Respiratory Disease Questionnaire (CRQ)
10 months
Generalized Anxiety Disorder - 7 (GAD - 7) Measure
10 months
6-Minute Walk Test
10 months
Patient Health Questionnaire - 9 (PHQ - 9)
10 months
Study Arms (1)
COPD undergoing pulmonary rehabilitation
EXPERIMENTAL45 individuals with COPD will complete the UCLA-LS scale, CRQ, HADS, and 6 minute walk test before and after pulmonary rehabilitation.
Interventions
A typical PR program will include exercise training, disease-specific and self-management strategies education, and will last 6 - 8 weeks
Eligibility Criteria
You may qualify if:
- A spirometry (FEV1/FVC \< 0.70) or physician-confirmed diagnosis of COPD
- Aged 18 years or more
- Ability to complete at least 60% of the PR program that includes exercise, education, and behaviour change intervention
- Ability to provide written informed consent.
- Abbreviations:
- FEV1: forced expiratory volume in 1 second FVC: forced vital capacity
You may not qualify if:
- Do not have sufficient language skills (non-English speaking or reduced cognition)
- Are unable to complete at least 60% of PR
- Fail to complete the primary outcome measure, the University of California, and Los Angeles Loneliness scale (UCLA-LS).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West Park Healthcare Centre
Toronto, Ontario, M6M 2J5, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Dina Brooks, PhD
McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2022
First Posted
June 28, 2022
Study Start
January 23, 2023
Primary Completion
October 31, 2023
Study Completion
November 30, 2023
Last Updated
May 23, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share